| Application no. and date | 15724454.2 (espacenet) (Federated) (European Patent Register), 20150508 | | Patent/reg. no. and date | DK/EP 3142689, 20201111 | | Publication date | 20170322 | | Priority no. and date | US 201461992771 P, 20140513 | | EP pub. no. and date |
EP 3142689 20170322 | | Effective date | | | Applicant/owner | BAVARIAN NORDIC A/S, Philip Heymans Alle 3, 2900 Hellerup, DK | | Applicant ref. no. | 1563975 | | Inventor | ROUNTREE, Ryan, 4029 Briarglen Drive
San Jose, CA 95118, US,
FOY, Susan, 504 Franklin Street
Mountain View, CA 94041, US,
MANDL, Stefanie, 1384 34th Avenue
San Francisco, CA 94122, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) | | Title | KOMBINATIONSBEHANDLING TIL BEHANDLING AF CANCER MED EN KOPPEVIRUS, SOM UDTRYKKER ET TUMORANTIGEN, OG ET MONOKLONALT ANTISTOF MOD TIM-3 | | Int. application no. | US2015029885 | | Int. publication no. | WO2015175340 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
